BH
INSIDER · MAZE · Maze Therapeutics, Inc. · PRESIDENT, R&D & CMO
Bernstein Harold
Every open-market transaction filed under this name, Sep 1 to Oct 1.
Filings
7
0 buys · 7 sells
Bought
—
open market, at cost
Sold
$1.4M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 1 | MAZE | Maze Therapeutics, Inc. | President, R&D & CMO | Sell | 16,141 | $26.93 | $435K | — |
| Sep 4 | MAZE | Maze Therapeutics, Inc. | President, R&D & CMO | Sell | 9,705 | $26.22 | $255K | — |
| Sep 3 | MAZE | Maze Therapeutics, Inc. | President, R&D & CMO | Sell | 59 | $25.78 | $2K | — |
| Sep 3 | MAZE | Maze Therapeutics, Inc. | President, R&D & CMO | Sell | 5,130 | $26.01 | $133K | — |
| Sep 2 | MAZE | Maze Therapeutics, Inc. | President, R&D & CMO | Sell | 625 | $27.12 | $17K | — |
| Sep 2 | MAZE | Maze Therapeutics, Inc. | President, R&D & CMO | Sell | 4,481 | $26.38 | $118K | — |
| Sep 1 | MAZE | Maze Therapeutics, Inc. | President, R&D & CMO | Sell | 16,141 | $26.36 | $426K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.